Top-News
Pharmazeutika Großbritannien

Hikma Pharmaceuticals Aktie

Aktie
WKN:  A0HG69 ISIN:  GB00B0LCW083 US-Symbol:  HKMPF
23,80 €
+0,20 €
+0,85%
02.05.25
Depot/Watchlist
Aktienanzahl *
221,89 Mio.
Marktkapitalisierung *
5,24 Mrd. €
Streubesitz
29,75%
Index-Zugehörigkeit
FTSE 100
IR-Website
zur Website
*Stand: 12.03.2025

Hikma Pharmaceuticals News

07.08.20 - Börse Online
DAX leicht im Plus: Jobaufbau in USA versöhnt Europas Anleger zum Wochenschluss
Der anhaltende Jobaufbau in den USA hat Europas Anlegern einen versöhnlichen Wochenabschluss bereitet. Der Dax legte am Freitagnachmittag 0,8 Prozent zu auf 12.691 Zähler, ...
28.05.20 - PR Newswire
Hikma launches Dicyclomine Hydrochloride Oral Solution
Hikma launches Dicyclomine Hydrochloride Oral Solution Receives first Competitive Generic Therapy Exclusivity from FDA PR Newswire
22.05.20 - PR Newswire
Hikma receives FDA approval for its generic Vascepa®
Hikma receives FDA approval for its generic Vascepa® PR Newswire
12.05.20 - PR Newswire
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP Sedative for patients on ventilators currently in short supply in the US PR Newswire
12.05.20 - PR Newswire
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP PR Newswire
11.05.20 - PR Newswire
Hikma launches employee matching donation campaign to support local US food banks and pantries
Hikma launches employee matching donation campaign to support local US food banks and pantries Campaign will help address significant increase in demand caused by COVID-...
04.05.20 - PR Newswire
Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
Altoida Inc. Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases Altoida's FDA-​cleared and CE Mark-​approved medical device and brain ...
31.03.20 - PR Newswire
Hikma confirms favourable ruling in generic Vascepa® patent suit
Hikma confirms favourable ruling in generic Vascepa® patent suit PR Newswire
27.02.20 - PR Newswire
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US
Hikma and Glenmark Pharmaceuticals Enter into Exclusive Licensing Agreement for Commercialising Ryaltris™ Seasonal Allergic Rhinitis Nasal Spray in the US Builds on Hikma's ...
09.01.20 - PR Newswire
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-​to-use medicine using Arestat™ technology Product designed to provide safer, more ...
18.11.19 - PR Newswire
Hikma Ventures leads Series A financing for development of Winterlight Labs' AI vocal technology to detect central nervous system disorders and track efficacy of treatments
Hikma Ventures leads Series A financing for development of Winterlight Labs' AI vocal technology to detect central nervous system disorders and track efficacy of treatments PR ...
23.09.19 - dpa-AFX
INDEX-MONITOR: Polymetal, Hikma und Meggitt im FTSE 100
Das Bergbauunternehmen Polymetal International , der Pharmakonzern Hikma sowie der Technologiekonzern Meggitt sind von diesem Montag an im britischen FTSE 100 zu finden.
17.09.19 - PR Newswire
Hikma launches prefilled syringes in the US
Hikma launches prefilled syringes in the US Heparin Sodium Injection in a ready-​to-use syringe is the first product using Hikma's new injectable manufacturing capability PR Newswire
05.09.19 - dpa-AFX
INDEX-MONITOR: Polymetal, Hikma und Meggitt ab 23. September im FTSE 100
Das Bergbauunternehmen Polymetal International , der Pharmakonzern Hikma sowie der Technologiekonzern Meggitt werden im September in den britischen FTSE 100 ...
02.09.19 - dpa-AFX
INDEX-MONITOR: JPMorgan erwartet Polymetal und Hikma in Kürze im FTSE 100
Das Bergbauunternehmen Polymetal International und der Pharmakonzern Hikma dürften nach Ansicht der US-Bank JPMorgan wohl in Kürze in den britischen Leitindex FTSE 100 ...
30.05.19 - PR Newswire
Hikma Ventures participates in $11 million funding round for Pillo Health
Hikma Ventures participates in $11 million funding round for Pillo Health PR Newswire
29.05.19 - PR Newswire
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-First Healthcare Platform for the Home
Pillo Health Raises $11M in Series-A Funding from Stanley Black & Decker and Samsung Ventures to Fuel Development of Voice-​First Healthcare Platform for the Home PR Newswire
02.05.19 - PR Newswire
Hikma Sponsors MIT Grand Hack to Support Global Healthcare Innovation
Hikma Sponsors MIT Grand Hack to Support Global Healthcare Innovation PR Newswire
02.04.18 - PR Newswire
Propeller Health Publishes Results From a Large Public Health Study on Asthma; Successfully Reduces the Burden of Asthma in Louisville
Propeller Health Publishes Results From a Large Public Health Study on Asthma; Successfully Reduces the Burden of Asthma in Louisville PR Newswire
20.12.17 - PR Newswire
Propeller Health Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance
Propeller Health Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance HITRUST Certification validates Propeller is committed ...

Newssuche

Videos

newspaper
30.04.25 +22,47%
Technical Trading: Cotton Long Chance
Cotton Long Typ: Turbo Open End WKN: VP6N8D Hebel: 3,80 Laufzeit: OpenEnd Einstieg: Market ... Mehr »